Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,
Could Trump Make A Big Weight Loss Drug Deal?
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would drugmakers agree to reduce their prices right away?
Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts weigh the pros and cons of the practice.
The weight loss drug revolution is shrinking America's waistline
Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of groundbreaking new weight-loss drugs is transforming how Americans shed pounds. Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029,
Illinois AG starts crackdown on weight-loss drug copycats
Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly producing misleading marketing content for drugs resembling Ozempic and Wegovy.
Should Medicaid Pay for Ozempic and Other Weight-Loss Drugs?
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
How use of weight-loss drugs such as Ozempic has grown in Washington state
Axios Visuals The emergence of groundbreaking weight-loss drugs is transforming how Americans shed pounds, including in Washington state. The big picture: Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029,
FDA issues draft guidance on developing weight loss drugs
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new ...
FierceBiotech6h
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Medscape6h
Retatrutide Produces Greatest Weight Loss
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...
Rolling Out10d
Weight loss drug and rare vision loss: Alarming study reveals link
New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...
A Block: Weight loss drug warning, dogs die in fire, firefighter laid to rest
News has the top news and weather for Jan. 3, 2025 including a warning about counterfeit weight loss drugs, dogs who were killed in a fire and more.
Arizona Couple Details 'Life-Changing’ Experience on Weight Loss Drugs — Including ‘Sulfur Burps’ (Exclusive)
Arizona couple Michael and Julie Carroll have lost a combined 177 lbs. on a GLP-1 weight loss drug. 'It gave me my ...